Mr. Schinecker, currently serving as Roche’s head of centralized and point-of-care solutions, will succeed Michael Heurer, who is retiring at the end of July.
Mr. Heurer had been serving as interim CEO of the $13 billion diagnostics unit, which includes diabetes care and personalized cancer treatments.
Roche also announced that Peter Voser will leave Roche’s board of directors by July.
More articles on pharmacy:
Sanofi poaches exec from Novartis
Eli Lilly’s migraine drug 1st approved to reduce cluster headaches: 4 notes
EpiPen shortage will drag on: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.